Clinical correlates of therapeutic response in bipolar disorder

Journal of Affective Disorders

Volumn 67, Issue 1-3, 2001, Pages 257-265

  Bowden, Charles L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bipolar disorder; Carbamazepine; Divalproex sodium; Lithium; Neuroletics; Valproate

Indexed keywords

CARBAMAZEPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE; STABILIZING AGENT; VALPROATE SEMISODIUM;

AGGRESSION; BIPOLAR DEPRESSION; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMPULSIVENESS; LONG TERM CARE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MIGRAINE; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOSIS; REVIEW;

AFFECT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM CARBONATE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0035723037     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(98)00160-8     Document Type: Review

References (84)

1. Who responds to prophylactic lithium?
2. Cyclothymic temperamental disorders
3. Criteria for the "soft" bipolar spectrum: Treatment implications
4. The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV
5. Gender, temperament and the clinical picture in dysphoric mixed mania: Findings from a French national study (EPIMAN)
6. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
7. Dysthymia and cyclothymia in psychiatric practice: A century after Kraepelin
8. Rapid cycling bipolar disorder II treatment of refractory rapid cycling with high-dose levo-thyroxine: A preliminary study
9. Testing definitions of dysphoric mania and hypomania: Prevalence, clinical characteristics and inter-episode stability
10. Social adjustment of remitted bipolar and unipolar out-patients: A comparison with age- and sex-matched controls
11. Anticonvulsants in Bipolar Elderly
12. Efficacy of divalproex vs lithium and placebo in the treatment of mania
13. Who enters therapeutic trials? Illness characteristics of patients in clinical drug studies of mania
14. Maintenance clinical trials in bipolar disorder: Design implications of the divalproex-lithium-placebo study
15. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder
16. The relationship between substance abuse and bipolar disorder
17. Comorbidity of migraine and major affective disorders
18. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder
19. A double-blind, placebo-controlled prophylaxis study of lamotrigine in rapid-cycling bipolar disorder
20. Predictors of side effects associated with lithium administration in children
21. Extent and determinants of burden among families of patients with affective disorders
22. Comorbidity of panic disorder in bipolar illness: Evidence from the epidemiologic catchment area survey
23. Mania following head injury: A report of two cases and a review of the literature
24. Agitated behaviors in the elderly, II. Preliminary results in the cognitively depressed
25. Patterns of treatment resistance in bipolar affective disorder
26. Bipolar II: Not so different when co-morbidity excluded
27. Comprehensive review of the psychiatric uses of valproate
28. The manic syndrome: Factors which may predict a patient's response to lithium, carbamazepine and valproate
29. Clinical factors in lithium carbonate prophylaxis failure
30. Prophylaxis with lithium carbonate: An update
31. The dexamethasone suppression test in mixed bipolar disorder
32. The expert consensus guideline series: Treatment of bipolar disorder
33. A double-blind comparison of valproate and lithium in the treatment of acute mania
34. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified
35. The challenge of predicting response to stabilizing lithium treatment. The importance of patient selection
36. Risperidone plus mood stabiliser versus placebo plus mood stabiliser for mood episodes in bipolar disorder: A combined efficacy analysis
37. Low dose valproate: A new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome
38. Sodium valproate has a prophylactic effect in migraine without aura. A triple-blind, placebo-controlled crossover study
39. Effect of sodium valproate in three patients with organic brain syndromes
40. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: A prospective, placebo-controlled comparison
41. Bipolar I: A five year prospective follow-up
42. Course of the manic-depressive cycle and changes caused by treatment
43. The addition of lithium carbonate to carbamazepine: Antidepressant efficacy in treatment-resistant depression
44. Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms
45. Adolescent bipolar illness and personality disorder
46. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide)
47. Myristoylated alanine-rich C kinase substrate (MARCKS): A molecular target for the therapeutic action of mood stabilizers in the brain?
48. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course
49. Valproate in the treatment of behavioral agitation in elderly patients with dementia
50. Divalproex sodium's antipanic effect in panic disorder: A placebo-controlled study
51. Lithium decreases membrane-associated protein kinase C in hippocampus: Selectivity for the alpha isozyme
52. Migraine prophylaxis with divalproex
53. A follow-up study of early onset psychosis: Comparison between outcome diagnoses of schizophrenia, mood disorders, and personality disorders
54. Differences and similarities in mixed and pure mania
55. Valproate in the treatment of behavioral agitation of dementia
56. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A prospective, randomised, double-blind, placebo-controlled multicenter study
57. Clinical subtypes of bipolar mixed states: Validating a broader European definition in 143 cases
58. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: Is there a bipolar II connection?
59. Head injury, bipolar disorder, and response to valproate
60. Treatment of mixed mania
61. Valproic acid and panic disorder
62. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses
63. One-month prevalence of mental disorders in the United States: Based on five Epidemiological Catchment Area sites
64. A differential response to treatment with divalproex sodium in patients with intractable headache
65. Benzodiazepine withdrawal: Overview and implications for the treatment of anxiety
66. Predictors of lithium prophylaxis effectiveness
67. Affective comorbidity in panic disorder: Is there a bipolar connection?
68. A meta-analysis of controlled trials of neuroleptic treatment in dementia
69. Mania: Diagnosis, state measurement and prediction of treatment response
70. The safety and efficacy of divalproex sodium in the prophylaxis of migraine headache: A multicenter double-blind, placebo-controlled trial
71. The effect of sodium valproate on disturbed behavior in dementia
72. Substance abuse and bipolar affective disorder
73. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases
74. Hypothalamic pituitary-adrenocortical function in mixed and pure mania
75. Depression during mania: Treatment response to lithium or divalproex
76. Increased prevalence of alcoholism in relatives of depressed and bipolar children
77. Outcome in mania: A four year prospective follow-up of 75 patients utilizing survival analysis
78. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania
79. Elevation of plasma lithium at the end of mania and some biochemical correlates
80. Valproate in the prevention of bipolar mood disorder: Two-year follow-up
81. Bipolar disorder in children: Misdiagnosis, underdiagnosis, and future directions
82. Alcoholism in manic-depressive (bipolar) illness: Familial illness, course of illness, and the primary-secondary distinction
83. Alcoholism and drug abuse in bipolar I unipolars and their acquaintances
84. Valproate in the treatment of post traumatic bipolar disorder in a psychogeriatric patient